Sign Up to like & get
recommendations!
0
Published in 2022 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13623
Abstract: A 38-year-old Caucasian female presented with 2 years of progressive involuntary movements, dysarthria, sialorrhea, dysphagia, gait impairment, and restlessness. She denied prior use of neuroleptics. Levodopa (400 mg/day), glycopyrrolate, pro-pranolol (40 mg/day), clonazepam (2 mg/day),…
read more here.
Keywords:
day;
treatment hyperkinetic;
hyperkinetic movements;
amantadine treatment ... See more keywords